复星医药(600196)披露为控股子公司提供担保进展,9月15日股价上涨1.62%
Sou Hu Cai Jing·2025-09-15 09:28

Group 1 - The core stock price of Fosun Pharma (600196) closed at 32.03 yuan on September 15, 2025, with a market capitalization of 85.534 billion yuan, reflecting a 1.62% increase from the previous trading day [1] - The stock opened at 31.53 yuan, reached a high of 32.45 yuan, and a low of 31.4 yuan, with a trading volume of 1.674 billion yuan and a turnover rate of 2.47% [1] - Fosun Pharma announced a guarantee for its subsidiaries, involving 11 entities including Fosun Pharma Industry, Fosun Industrial, and Fosun Health, with a total guarantee amount of 25 million USD and 1.226 billion yuan [1] Group 2 - The guarantee method primarily involves joint liability guarantees or maximum joint liability guarantees, with some guarantees having counter-guarantee arrangements [1] - As of September 12, 2025, the actual external guarantee balance of the group was approximately 23.6024 billion yuan, accounting for 49.94% of the audited net assets as of the end of 2024, with no overdue guarantees [1] - The guarantee has undergone internal decision-making procedures and does not require further approval, although some guaranteed entities have asset-liability ratios exceeding 70% [1]